Betty Bromage: Britain’s Fearless Wing Walker Continues to Inspire at 97
Defying Age and Expectations For many people, their later years are associated with slowing down, taking life at a gentler pace and enjoying a well-earned retirement. Betty Bromage has chosen an altogether different path. At the age of 97, the Gloucestershire grandmother has once again captured the nation’s imagination Continue Reading
India’s Contribution to the Next Generation of AI Robots
The future of household robots depends on everyday people in India, who record routine tasks to provide AI with vital “egocentric data.” This data helps robots learn human interactions and complete practical tasks. While the market for humanoid robots is booming, concerns about its impact on employment persist, especially for informal workers.
T-Rex Leather Handbag Auction: A Fusion of Fashion and Science
A unique luxury handbag made from “T-Rex leather” is set for auction in Paris, expected to fetch between €300,000 and €500,000. Created through advanced biotechnology, it combines fashion and science, featuring distinct dinosaur-inspired designs. The project raises questions about its authenticity, but highlights innovations in sustainable luxury materials.
Adolescence: The BBC Drama About Boys, Men and the Silence Between Them
There are television dramas that arrive quietly, and then there are dramas that kick the door open and demand the country listens. Adolescence was one of those rare pieces of television that did not just tell a story. It held up a mirror. Broadcast on the BBC, the drama explored Continue Reading
Sister Irmingard’s Delight: The Nun Who Tried Doner Kebab
A 92-year-old nun from Germany, Sister Irmingard, became an internet sensation after joyfully tasting a doner kebab for the first time. The video of her delight, alongside a bottle of Coca-Cola, has garnered over seven million views, highlighting the simple joys that can unite people online amidst widespread negativity.
Targeting Ageing: Cambridge’s Breakthrough Drug Development
Cambridge biotechnology startup LinkGevity is developing a revolutionary drug, LINK-001, to target necrosis—believed to be central to ageing. This holistic treatment aims to slow or reverse the ageing process by preventing destructive cellular processes. Early trials are expected by late 2025, with potential implications for various degenerative diseases.
